Jingying Jia

12PUBLICATIONS
33CO-AUTHORS
PharmacogenomicsToxicology (incl. clinical toxicology)Traditional Chinese medicine and treatmentsFood properties (incl. characteristics and health benefits)Predictive and prognostic markers
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (12)

|Jul 18, 2026
A Physiologically Based Pharmacokinetic Model to Predict Potential Drug-Drug Interactions of TPN171, a Novel Phosphodiesterase Type 5 Inhibitor.

|Apr 20, 2026
Mass balance study of [14C]Netanasvir Phosphate in healthy Chinese participants.

|Mar 17, 2025
A Phase I Study to Evaluate the Safety, Tolerability, Pharmacokinetics of BGT-002, a Novel ATP-Citrate Lyase Inhibitor, in Healthy Chinese Subjects.

Yun Liu, Chengyin Yu, Yifan Zhang

|Feb 17, 2025
Hemodynamic and Pharmacokinetic Interactions of TPN171 with Alcohol in Healthy Male Subjects.

Jie Cheng, Hongjie Qian, Yu Wang

|Jun 03, 2024
Evaluation of Drug-Drug Interaction Between Henagliflozin and Hydrochlorothiazide in Healthy Chinese Volunteers.

Qian Chen, Chengyin Yu, Qingqing Wu

|Mar 07, 2024
Safety, pharmacokinetics, and pharmacodynamics in healthy Chinese volunteers treated with SC0062, a highly selective endothelin-A receptor antagonist.

Yun Liu, Wei Wang, Hongjie Qian

Pageof 2

Frequent Collaborators

3 joint publications

Qian Chen

2 joint publications

Zhen Wang

2 joint publications

Hongjie Qian

2 joint publications

Chen Yu